UprimaŽ (apomorphine HCl tablets) sublingual Presentation to the Urology Subcommittee of the Advisory Committee for Reproductive Health Drugs April 10, 2000 TAP HOLDINGS INC.

5/3/00


Click here to start


Table of Contents

UprimaŽ (apomorphine HCl tablets) sublingual Presentation to the Urology Subcommittee of the Advisory Committee for Reproductive Health Drugs April 10, 2000 TAP HOLDINGS INC.

Speakers

TAP Participants

TAP Participants (cont.)

TAP Consultants

TAP Consultants

TAP Presentations

Topics Identified in FDA Briefing Document

Erectile Dysfunction (ED)

Erectile Dysfunction

Erectile Dysfunction

Age Related Changes in Erectile Status

Massachusetts Male Aging Study

ED Population

Introduction to Apomorphine

Introduction to UprimaŽ

Introduction to UprimaŽ

Proposed Indication

Doses

Rationale for UprimaŽ Treatment of ED

Rationale for UprimaŽ Treatment of ED

UprimaŽ Clinical Trials

Author: Andrea_Poffenberger